Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/6239

Sodium xylenesulfonate: Target Organs and Levels of Evidence for TR-464

Toxicology and Carcinogenesis Studies of Technical Grade Sodium Xylene Sulfonate (CASRN 1300-72-7) in F344 Rats and B6C3F1 Mice (Dermal Studies)

Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Sodium xylenesulfonate
1300-72-7
Topical Application
R&M: 120.0,39.9,13.2,4.5,1.5,0 MG/KG
Southern Research Institute

Levels of Evidence: None



Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Sodium xylenesulfonate
1300-72-7
12/05/1995 Topical Application
R: 0, 60, 120, OR 240 MG/KG M: 0, 182, 364, OR 727 MG/KG (50/SEX/GROUP)
Battelle Columbus Laboratory

Levels of Evidence

Male Rats: No Evidence
Female Rats: No Evidence
Type Organ/Tissue (Lesion)
May Have Been Related
  • Skin: EPIDERMAL HYPERPLASIA 1/50 0/50 4/50 5/50
Male Mice: No Evidence
Type Organ/Tissue (Lesion)
May Have Been Related
  • Skin: EPIDERMAL HYPERPLASIA 1/50 0/50 4/50 5/50
Female Mice: No Evidence